Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator.
Varey AHR, Li I, El Sharouni MA, Simon J, Dedeilia A, Ch'ng S, Saw RPM, Spillane AJ, Shannon KF, Pennington TE, Rtshiladze M, Stretch JR, Nieweg OE, van Akkooi A, Sullivan RJ, Boland GM, Gershenwald JE, van Diest PJ, Scolyer RA, Long GV, Thompson JF, Lo SN.
Varey AHR, et al.
J Clin Oncol. 2024 Apr 1;42(10):1169-1180. doi: 10.1200/JCO.23.01020. Epub 2024 Feb 5.
J Clin Oncol. 2024.
PMID: 38315961
These models were robust on external validations and may be used in everyday practice both with (ideally) and without performing SN biopsy to identify high-risk patients for further management strategies. An online tool will be available at the MIA website (Risk Prediction …
These models were robust on external validations and may be used in everyday practice both with (ideally) and without performing SN biopsy t …